BioMarin Announces First Quarter 2020 Total Revenue Growth of 25% to $502 million
Go back to BioMarin Announces First Quarter 2020 Total Revenue Growth of 25% to $502 million| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 65.69 -0.84 (1.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.53 | 52 Week High | $108.96 | |||
| Open | $65.24 | 52 Week Low | $62.12 | |||
| Day High | $65.75 | P/E | N/A | |||
| Day Low | $64.01 | EPS | $-1.27 | |||
| Volume | 96,841 | |||||
